SCHEMBL4848788

SCHEMBL4848788

CC(Cl)CCOCCC(C)Cl

nearest known ligand 0.39

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.31
TSHR P16473 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9120004 0.85
SCHEMBL6412327 0.83
SCHEMBL6936627 0.83
SCHEMBL10766674 0.83
SCHEMBL6938476 0.79
SCHEMBL6936640 0.79
SCHEMBL9118312 0.78
SCHEMBL9118309 0.75
SCHEMBL1248824 0.73
SCHEMBL42956 0.72 ALDH1A1 (0.48) ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109354706-B Application of multifunctional polyurethane prepolymer in surface modification of medical catheter 淮海工学院 2021-03-26 CN claimed
EP-4736989-A1 ACIDIC GAS-ABSORBING LIQUID AND ACIDIC GAS REDUCTION METHOD AGC INC. (JP) 2026-05-06 EP disclosed
EP-4736988-A1 ACIDIC GAS-ABSORBING LIQUID AND ACIDIC GAS REDUCTION METHOD AGC INC. (JP) 2026-05-06 EP disclosed
US-20260115649-A1 ACIDIC GAS-ABSORBING LIQUID AND ACIDIC GAS REDUCTION METHOD AGC Inc. (JP) 2026-04-30 US disclosed
US-20260115646-A1 ACIDIC GAS-ABSORBING LIQUID AND ACIDIC GAS REDUCTION METHOD AGC Inc. (JP) 2026-04-30 US disclosed
US-20220389308-A1 WAVELENGTH CONVERSION FILM, WAVELENGTH CONVERSION FILM FORMING COMPOSITION, AND CLUSTER-CONTAINING QUANTUM DOT PRODUCTION METHOD TOKYO OHKA KOGYO CO., LTD. (JP) 2022-12-08 US disclosed
CN-109071523-B Urea compound, preparation method and medical application thereof 恩瑞生物医药科技(上海)有限公司 2022-05-31 CN disclosed
EP-3998324-A1 WAVELENGTH CONVERSION FILM, WAVELENGTH CONVERSION FILM FORMING COMPOSITION, AND CLUSTER-CONTAINING QUANTUM DOT PRODUCTION METHOD TOKYO OHKA KOGYO CO., LTD. (JP) 2022-05-18 EP disclosed
CN-114477202-A Organic functional group modified MCM molecular sieve and preparation method and application thereof 中国石油化工股份有限公司 2022-05-13 CN disclosed
CN-114477212-A Organic functional group modified SBA molecular sieve and preparation method and application thereof 中国石油化工股份有限公司 2022-05-13 CN disclosed
US-6235771-B1 AIDS THERPAY TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2001-05-22 US disclosed
WO-2000037455-A1 BENZOTHIEPIN-ANILIDE DERIVATIVES, THEIR PRODUCTION AND THEIR USE FOR ANTAGONIZING CCR-5 TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2000-06-29 WO disclosed
EP-0580541-B1 Piperidine derivatives of benzimidazole as antihistaminic and antiallergic agents ESPANOLA PROD QUIMICOS (ES) 1999-10-06 EP disclosed
US-5322850-A Antiallergic piperidine derivatives of benzimidazole FABRICA ESPANOLA DE PRODUCTOS QUIMICOS Y FARMACEUTICOS, S.A. (ES) 1994-06-21 US disclosed
EP-0580541-A1 New piperidine derivatives of benzimidazole as antihistanminic and antiallergic agents FABRICA ESPANOLA DE PRODUCTOS QUIMICOS Y FARMACEUTICOS, S.A. (FAES) (ES) 1994-01-26 EP disclosed
US-5202444-A 1L-1,2:5,6-di-O-cyclohexylidene-chiro-inositol derivatives; intermediates for diols and hydroxycarboxylic acids and esters and antibiotics THE YOKOHAMA RUBBER CO., LTD. (JP) 1993-04-13 US disclosed
EP-0055428-B1 BIS-(3-SULFOPROPYL)ETHERS, PROCESS FOR THEIR PREPARATION AND THEIR USE AS ALKYLATING AGENTS FOR ORGANIC BASES Agfa-Gevaert AG (DE) 1984-03-14 EP disclosed
EP-0055428-A1 Bis-(3-sulfopropyl)ethers, process for their preparation and their use as alkylating agents for organic bases Agfa-Gevaert AG (DE) 1982-07-07 EP disclosed
US-3998890-A INSECTICIDES, MITICIDES CIBA-GEIGY CORPORATION (US) 1976-12-21 US disclosed
US-3957885-A INSECTICIDES CIBA-GEIGY CORPORATION (US) 1976-05-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260115646-A1 ACIDIC GAS-ABSORBING LIQUID AND ACIDIC GAS REDUCTION METHOD CA7, CA3, CA12 ALDH1A1 2627/4885TSHR 4085/4885
US-20260115649-A1 ACIDIC GAS-ABSORBING LIQUID AND ACIDIC GAS REDUCTION METHOD CA7, CA9, CA12 ALDH1A1 2256/4885TSHR 4262/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.